Topical tacrolimus and pimecrolimus and the risk of cancerhow much cause for concern?ORMEROD, A. D.Author informationAberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, U.K.E-mail: [email protected]British Journal of Dermatology 153(4):p 701-705, October 2005.Copyright © 2005 British Association of Dermatologists
